United Kingdom

Ionis Pharmaceuticals Inc (IONS.OQ)

IONS.OQ on NASDAQ Stock Exchange Global Select Market

8:59pm GMT
Change (% chg)

$-0.59 (-1.02%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Stanley Crooke

73 1991 Chairman of the Board, President, Chief Executive Officer

Elizabeth Hougen

56 2013 Chief Financial Officer, Senior Vice President - Finance

Brett Monia

56 2018 Chief Operating Officer and Senior Vice President, Drug Discovery and Corporate Development

Patrick O'Neil

44 2016 Senior Vice President, Legal, General Counsel, Chief Compliance Officer and Corporate Secretary

C. Frank Bennett

61 2006 Senior Vice President - Antisense Research